Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Toxicol Pathol ; 45(4): 493-505, 2017 06.
Artigo em Inglês | MEDLINE | ID: mdl-28580885

RESUMO

We previously reported the contribution of constitutive androstane receptor (CAR) in cytotoxicity-related hepatocarcinogenesis induced by oxadiazon (OX) or acifluorfen (ACI), two pesticides categorized as protoporphyrinogen oxidase (PROTOX) inhibitors. The molecular characteristics of preneoplastic and neoplastic lesions induced by OX and ACI were immunohistochemically compared to those by phenobarbital (PB), a typical CAR activator, in wild-type (WT) and CAR knockout (CARKO) mice after diethylnitrosamine initiation. We focused on changes in ß-catenin and its transcriptional product glutamine synthetase (GS). In PB-promoted foci and adenomas, nuclear accumulation of mutated ß-catenin was increased with high frequency. PB treatment also increased the multiplicity and area of GS-positive foci and adenomas in WT mice. No foci and adenomas showed nuclear accumulation of ß-catenin and expression of GS in CARKO mice, similar to both genotypes of mice treated with OX and ACI. Interestingly, hepatocellular carcinoma induced in ACI-treated WT mice showed nuclear accumulation of ß-catenin and was positive for GS. Our results indicated that ß-catenin mutations were not involved in early-stage hepatocarcinogenesis induced by PROTOX inhibitors in mice, although activation of ß-catenin and CAR is important in PB-induced tumorigenesis. The significant differences in molecular profiles suggested involvements of multiple mode of actions for hepatocarcinogenesis induced by PROTOX inhibitors.


Assuntos
Carcinogênese/genética , Inibidores Enzimáticos/toxicidade , Neoplasias Hepáticas Experimentais/genética , Nitrobenzoatos/toxicidade , Oxidiazóis/toxicidade , beta Catenina/genética , Animais , Carcinogênese/induzido quimicamente , Carcinógenos/toxicidade , Proliferação de Células/efeitos dos fármacos , Receptor Constitutivo de Androstano , Glutamato-Amônia Ligase/genética , Glutamato-Amônia Ligase/metabolismo , Fígado/efeitos dos fármacos , Fígado/patologia , Neoplasias Hepáticas Experimentais/induzido quimicamente , Masculino , Camundongos , Camundongos Endogâmicos C3H , Camundongos Knockout , Mutação , Fenobarbital/toxicidade , Protoporfirinogênio Oxidase/antagonistas & inibidores , Protoporfirinogênio Oxidase/metabolismo , Receptores Citoplasmáticos e Nucleares/genética , Receptores Citoplasmáticos e Nucleares/metabolismo
2.
Reprod Biol ; 17(1): 111-119, 2017 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-28215489

RESUMO

It has been reported that neonatal exposure to estrogens at relatively low doses can induce early onset anovulation as a delayed effect in female rats. Dysfunction of kisspeptin neurons in the anteroventral periventricular nucleus (AVPV) was proposed to be a trigger for this effect. To determine the roles of estrogen receptor (ER) subtypes in the induction of delayed effects, we conducted a series of experiments using Donryu rats to examine whether neonatal injection of an ERα agonist (PPT), an ERß agonist (DPN) or an ERα antagonist (ICI) could induce delayed effects. Also, involvement of the kisspeptin neurons in the AVPV for induction of delayed effect by PPT and DPN was investigated. We observed that neonatal exposure to PPT, DPN and ICI induced the early onset of abnormal estrous cyclicity after sexual maturation, suggesting that the compounds capable of inducing delayed effects are not limited to ERα agonists. On the other hand, the data suggested the possibility that DPN and ICI functioned partially as ERα agonists in the neonatal brain. Regardless of the agents used, there is a possibility that dysfunction of kisspeptin neurons in the AVPV might contribute to induction of early onset anovulation.


Assuntos
Receptor alfa de Estrogênio/agonistas , Receptor beta de Estrogênio/agonistas , Estrogênios não Esteroides/toxicidade , Hipotálamo Anterior/efeitos dos fármacos , Distúrbios Menstruais/induzido quimicamente , Ovário/efeitos dos fármacos , Útero/efeitos dos fármacos , Animais , Animais Recém-Nascidos , Anovulação/induzido quimicamente , Anovulação/metabolismo , Anovulação/patologia , Relação Dose-Resposta a Droga , Antagonistas do Receptor de Estrogênio/administração & dosagem , Antagonistas do Receptor de Estrogênio/metabolismo , Antagonistas do Receptor de Estrogênio/toxicidade , Receptor alfa de Estrogênio/antagonistas & inibidores , Receptor alfa de Estrogênio/metabolismo , Receptor beta de Estrogênio/metabolismo , Estrogênios não Esteroides/administração & dosagem , Estrogênios não Esteroides/metabolismo , Feminino , Hipotálamo Anterior/metabolismo , Hipotálamo Anterior/patologia , Kisspeptinas/metabolismo , Distúrbios Menstruais/metabolismo , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Neurônios/patologia , Tamanho do Órgão/efeitos dos fármacos , Ovário/metabolismo , Ovário/patologia , Gravidez , Distribuição Aleatória , Ratos , Distribuição Tecidual , Toxicocinética , Útero/metabolismo , Útero/patologia
3.
Neurotoxicology ; 56: 64-75, 2016 09.
Artigo em Inglês | MEDLINE | ID: mdl-27395752

RESUMO

Selective estrogen receptor modulators (SERMs) are a class of therapeutic chemicals which present tissue-specific estrogen receptor modulating activity. Neonatal exposure to SERMs has been reported to adversely affect central nervous system development, however, mechanism and involvement of hypothalamic kisspeptin neurone in this impairment remains undetermined. To clarify this uncertainty, neonates from female Donryu rats were subcutaneously injected with raloxifene (RLX) at 0.1, 1, and 10mg/kg or tamoxifen (TMX) at 10mg/kg on postnatal day 0, and then hypothalamic KiSS1 mRNA expression and gonadotropin levels were investigated during young adulthood and estrous cycling was monitored until middle age. Treatment with RLX or TMX at 10mg/kg significantly depressed luteinizing hormone surge levels and KiSS1 mRNA expression in the anteroventral periventricular nucleus (AVPV), the control center of estrous cyclicity. The 10mg/kg TMX group also showed decreased levels of follicle-stimulating hormone and KiSS1 mRNA expression in the arcuate nucleus (ARC). Early cessation of normal estrous cycling was observed in the 10mg/kg RLX group, while the estrous cycle in the 10mg/kg TMX group had ceased by the start of the analysis. The same dose of tamoxifen or raloxifene had either weak-estrogenic or anti-estrogenic activity on the uterus, respectively; however, treatment in adulthood with both SERMs did not affect KiSS1 mRNA expression in either the AVPV or ARC in the present study. These results indicate that neonatal exposure to SERMs could disrupt neuroendocrine development and postnatal reproductive function through the alteration of kisspeptin neurons.


Assuntos
Deficiências do Desenvolvimento/induzido quimicamente , Doenças do Sistema Endócrino/induzido quimicamente , Hipotálamo/patologia , Kisspeptinas/metabolismo , Neurônios/metabolismo , Moduladores Seletivos de Receptor Estrogênico/toxicidade , Fatores Etários , Animais , Animais Recém-Nascidos , Peso Corporal/efeitos dos fármacos , Deficiências do Desenvolvimento/patologia , Modelos Animais de Doenças , Doenças do Sistema Endócrino/patologia , Estradiol/análogos & derivados , Estradiol/farmacologia , Ciclo Estral/efeitos dos fármacos , Feminino , Hormônios/metabolismo , Hipotálamo/efeitos dos fármacos , Kisspeptinas/genética , Neurônios/efeitos dos fármacos , Ovariectomia , Gravidez , Progesterona/farmacologia , Cloridrato de Raloxifeno/farmacologia , Ratos , Tamoxifeno/farmacologia
4.
Toxicol Sci ; 151(2): 271-85, 2016 06.
Artigo em Inglês | MEDLINE | ID: mdl-26928356

RESUMO

Acifluorfen (ACI), a protoporphyrinogen oxidase (PROTOX) inhibitor herbicide, promotes the accumulation of protoporphyrin IX (PPIX), and induces tumors in the rodent liver. Porphyria is a risk factor for liver tumors in humans; however, the specific mechanisms through which ACI induces hepatocarcinogenesis in rodents are unclear. Here, we investigated the mode of action of ACI-induced hepatocarcinogenesis, focusing on constitutive androstane receptor (CAR, NR1I3), which is essential for the development of rodent liver tumors in response to certain cytochrome P450 (CYP) 2B inducers. Dietary treatment with 2500 ppm ACI for up to 13 weeks increased Cyp2b10 expression in the livers of wild-type (WT) mice, but not in CAR-knockout (CARKO) mice. Microscopically, ACI treatment-induced cytotoxic changes, including hepatocellular necrosis and inflammation, and caused regenerative changes accompanied by prolonged increases in the numbers of proliferating cell nuclear antigen-positive hepatocytes in WT mice. In contrast, these cytotoxic and regenerative changes in hepatocytes were significantly attenuated, but still observed, in CARKO mice. ACI treatment also increased liver PPIX levels similarly in both genotypes; however, no morphological evidence of porphyrin deposition was found in hepatocytes from either genotype. Treatment with 2500 ppm ACI for 26 weeks after initiation with diethylnitrosamine increased the incidence and multiplicities of altered foci and adenomas in hepatocytes from WT mice; these effects were significantly reduced in CARKO mice. These results indicated that prolonged cytotoxicity in the liver was a key factor for ACI-induced hepatocarcinogenesis, and that CAR played an important role in ACI-induced liver injury and tumor development in mice.


Assuntos
Adenoma/induzido quimicamente , Transformação Celular Neoplásica/efeitos dos fármacos , Doença Hepática Induzida por Substâncias e Drogas/etiologia , Neoplasias Hepáticas/induzido quimicamente , Fígado/efeitos dos fármacos , Nitrobenzoatos/toxicidade , Receptores Citoplasmáticos e Nucleares/metabolismo , Adenoma/genética , Adenoma/metabolismo , Adenoma/patologia , Animais , Hidrocarboneto de Aril Hidroxilases/metabolismo , Proliferação de Células/efeitos dos fármacos , Transformação Celular Neoplásica/genética , Transformação Celular Neoplásica/metabolismo , Transformação Celular Neoplásica/patologia , Doença Hepática Induzida por Substâncias e Drogas/genética , Doença Hepática Induzida por Substâncias e Drogas/metabolismo , Doença Hepática Induzida por Substâncias e Drogas/patologia , Receptor Constitutivo de Androstano , Família 2 do Citocromo P450/metabolismo , Dietilnitrosamina/toxicidade , Genótipo , Fígado/metabolismo , Fígado/patologia , Neoplasias Hepáticas/genética , Neoplasias Hepáticas/metabolismo , Neoplasias Hepáticas/patologia , Masculino , Camundongos Endogâmicos C3H , Camundongos Knockout , Necrose , Estresse Oxidativo/efeitos dos fármacos , Fenótipo , Antígeno Nuclear de Célula em Proliferação/metabolismo , Protoporfirinas/metabolismo , Receptores Citoplasmáticos e Nucleares/deficiência , Receptores Citoplasmáticos e Nucleares/genética , Esteroide Hidroxilases/metabolismo , Fatores de Tempo
5.
Reprod Toxicol ; 60: 33-8, 2016 04.
Artigo em Inglês | MEDLINE | ID: mdl-26820455

RESUMO

Neonatal exposure to 17alpha-ethynylestradiol (EE) at relatively low doses leads to delayed effects characterized by the early onset of age-related anovulation. Kisspeptin neurons in the anteroventral periventricular nucleus (AVPV), located at the anterior hypothalamus, are proposed to play key roles in appearance of these delayed effects after maturation. To understand the initial changes, we investigated Kiss1 mRNA expression in the anterior and posterior hypothalamus before weaning in female rats that received neonatal exposure to EE at various doses (0.002-2000µg/kg). The level of Kiss1 mRNA in the anterior hypothalamus was decreased from 0.002µg/kg which did not induce delayed effects. In the posterior hypothalamus, Kiss1 mRNA expression did not differ among the groups except 2000µg/kg group. These results suggest that neonatal exposure to EE affects the development of kisspeptin neurons and kisspeptin neurons in the AVPV are highly susceptible to neonatal EE treatment.


Assuntos
Estrogênios/farmacologia , Etinilestradiol/farmacologia , Hipotálamo Anterior/efeitos dos fármacos , Kisspeptinas/genética , Neurônios/efeitos dos fármacos , Animais , Animais Recém-Nascidos , Feminino , Hormônio Foliculoestimulante/sangue , Hipotálamo Anterior/metabolismo , Hormônio Luteinizante/sangue , Masculino , Mucosa/efeitos dos fármacos , Mucosa/patologia , Neurônios/metabolismo , Ovário/efeitos dos fármacos , Ovário/crescimento & desenvolvimento , RNA Mensageiro/metabolismo , Ratos , Útero/efeitos dos fármacos , Útero/crescimento & desenvolvimento , Vagina
6.
Food Chem Toxicol ; 88: 75-86, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26710982

RESUMO

Oxadiazon (OX) is a protoporphyrinogen oxidase-inhibiting herbicide that induces porphyria and liver tumors in rodents. Although porphyria is generally considered to be a risk factor for liver tumor development, the mechanisms through which OX mediates tumor development are unclear. Therefore, in this study, we investigated the mechanisms of tumor development by focusing on constitutive active/androstane receptor (CAR), which is essential for the development of tumors in response to several chemicals. After 1, 4, or 13 weeks of dietary treatment with 1000 ppm OX, hepatic Cyp2b10 expression was induced in wild-type (WT) mice. However, this effect was blocked in CAR-knockout (CARKO) mice. Hepatic Cyp4a10 expression, indicative of peroxisome proliferator-activated receptor α (PPARα) activation, and cytotoxic changes in hepatocytes were also observed in both groups of mice. After initiation by diethylnitrosamine, 26-week treatment with OX resulted in an increase in proliferative lesions, including foci and adenomas, in both genotypes, and the incidence and multiplicity of proliferative lesions in CARKO mice were higher than those in control mice but lower than those in WT mice. These results suggested that CAR, PPARα activation, and cytotoxicity were involved in the development of liver tumors. Moreover, porphyrin was not apparently involved in OX-induced tumor development.


Assuntos
Neoplasias Hepáticas/induzido quimicamente , Oxidiazóis/toxicidade , PPAR alfa/metabolismo , Receptores Citoplasmáticos e Nucleares/metabolismo , Animais , Carcinogênese/induzido quimicamente , Morte Celular , Células Cultivadas , Receptor Constitutivo de Androstano , Hepatócitos/efeitos dos fármacos , Herbicidas/toxicidade , Masculino , Camundongos , PPAR alfa/genética , Receptores Citoplasmáticos e Nucleares/genética
7.
Biol Reprod ; 93(2): 32, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26134866

RESUMO

Neonatal exposure to estrogens is known to cause delayed effects, a late-occurring adverse effect on adult female reproductive functions, such as early onset of age-matched abnormal estrous cycling. However, the critical period in which neonates are sensitive to delayed effects inducible by exogenous estrogen exposure has not been clearly identified. To clarify this window, we examined the intensity and timing of delayed effects using rats exposed to ethynylestradiol (EE) at various postnatal ages. After subcutaneous administration of a single dose of EE (20 µg/kg, which induces delayed effects) on Postnatal Day (PND) 0, 5, 10, or 14 in Wistar rats, hypothalamic and hormonal alterations in young adults and long-term estrous cycling status were investigated as indicators of delayed effects. In young adults, peak luteinizing hormone concentrations at the time of the luteinizing hormone surge showed a decreasing trend, and KiSS1 mRNA expression of the anterior hypothalamus and number of KiSS1-positive cells in the anteroventral periventricular nucleus were significantly decreased in the PND 0, 5, and 10 groups. The reduction in KiSS1 mRNA and KiSS1-postive cells was inversely correlated with age at time of exposure. These groups also exhibited early onset of abnormal estrous cycling, starting from 17 wk of age in the PND0 group and 19 wk of age in the PND5 and 10 groups. These indicators were not apparent in the PND14 group. Our results suggest that PND0-PND10 is the critical window of susceptibility for delayed effects, and PND14 is presumed to be the provisional endpoint of the window.


Assuntos
Etinilestradiol/toxicidade , Envelhecimento , Animais , Animais Recém-Nascidos , Peso Corporal/efeitos dos fármacos , Ciclo Estral/efeitos dos fármacos , Etinilestradiol/sangue , Feminino , Hormônio Foliculoestimulante/sangue , Hipotálamo/efeitos dos fármacos , Hipotálamo/crescimento & desenvolvimento , Hipotálamo Anterior/metabolismo , Kisspeptinas/biossíntese , Kisspeptinas/genética , Hormônio Luteinizante/sangue , Gravidez , Efeitos Tardios da Exposição Pré-Natal , RNA Mensageiro/biossíntese , RNA Mensageiro/genética , Ratos , Ratos Wistar , Diferenciação Sexual/efeitos dos fármacos , Vagina/efeitos dos fármacos , Vagina/crescimento & desenvolvimento , Doenças Vaginais/induzido quimicamente , Doenças Vaginais/patologia
8.
Food Chem Toxicol ; 83: 201-9, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-26115596

RESUMO

Ginkgo biloba extract (GBE) is commonly used as a herbal supplement. The National Toxicology Program (NTP) study of GBE reported clear evidence of hepatocarcinogenicity in mice. To clarify the mode of action (MOA) for hepatocarcinogenesis by GBE, we investigated the involvement of the constitutive androstane receptor (CAR) in hepatocarcinogenesis induced by GBE using CAR-knockout (CARKO) and wild type (WT) mice. We used the same lot of GBE that was used for the NTP study. In 1-week GBE dietary treatment, hepatocellular DNA replication was increased in WT mice but not in CARKO mice. In 4- or 13-week treatment, greater hepatic Cyp2b10 induction and hepatocellular hypertrophy were observed in WT mice, whereas these effects of GBE were much smaller in CARKO mice. In a two-stage hepatocarcinogenesis model initiated by diethylnitrosamine, 27-week treatment with GBE resulted in an increase of eosinophilic altered foci and adenomas in WT mice. By contrast, foci and adenomas were clearly less evident in CARKO mice. These results indicate that GBE-induced hepatocarcinogenesis is mainly CAR-mediated. Since CAR-mediated MOA for hepatocarcinogenesis in rodents is considered to be qualitatively implausible for humans, our findings would be helpful to evaluate the carcinogenic characterization of GBE to humans.


Assuntos
Cocarcinogênese/metabolismo , Suplementos Nutricionais/efeitos adversos , Ginkgo biloba/química , Hepatomegalia/etiologia , Neoplasias Hepáticas/etiologia , Extratos Vegetais/efeitos adversos , Receptores Citoplasmáticos e Nucleares/agonistas , Adenoma de Células Hepáticas/induzido quimicamente , Adenoma de Células Hepáticas/etiologia , Adenoma de Células Hepáticas/metabolismo , Adenoma de Células Hepáticas/patologia , Animais , Hidrocarboneto de Aril Hidroxilases/química , Hidrocarboneto de Aril Hidroxilases/genética , Hidrocarboneto de Aril Hidroxilases/metabolismo , Carcinógenos/química , Carcinógenos/toxicidade , Cocarcinogênese/patologia , Receptor Constitutivo de Androstano , Indutores das Enzimas do Citocromo P-450/efeitos adversos , Família 2 do Citocromo P450 , Replicação do DNA , Dietilnitrosamina/agonistas , Dietilnitrosamina/toxicidade , Hepatomegalia/metabolismo , Hepatomegalia/patologia , Japão , Fígado/efeitos dos fármacos , Fígado/metabolismo , Fígado/patologia , Neoplasias Hepáticas/induzido quimicamente , Neoplasias Hepáticas/metabolismo , Neoplasias Hepáticas/patologia , Masculino , Camundongos Endogâmicos C3H , Camundongos Knockout , Receptores Citoplasmáticos e Nucleares/genética , Receptores Citoplasmáticos e Nucleares/metabolismo , Esteroide Hidroxilases/química , Esteroide Hidroxilases/genética , Esteroide Hidroxilases/metabolismo , Testes de Toxicidade Subcrônica
9.
Reprod Toxicol ; 57: 21-8, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25975844

RESUMO

To determine whether it is the hypothalamic-pituitary axis or the ovary that plays the predominant role in abnormal estrous cycling induction by postnatal exposure to estrogenic compounds, female rats were subcutaneously injected with 100mg/kg p-tert-octylphenol or vehicle for 5 or 15 days after birth (OP-PND5, OP-PND15 or control). Ovaries were exchanged between control and treated groups on PND28. Controls receiving control or OP-PND5 ovaries showed normal cycles within 4 weeks after the exchange, and corpora lutea were detected in transplanted ovaries. Controls receiving OP-PND15 ovaries consistently increased persistent estrus (PE). OP-PND15 rats receiving control or OP-PND15 ovaries immediately descended into PE, and transplanted ovaries were atrophic with cystic follicles, indicating anovulation. OP-PND5 rats receiving control or OP-PND5 ovaries showed early onset of PE after normal cycling. The hypothalamic-pituitary axis is predominant in abnormal cycling induction by postnatal exposure to OP. OP-PND15 ovaries were impaired compared to other groups.


Assuntos
Estrogênios não Esteroides/toxicidade , Sistema Hipotálamo-Hipofisário/efeitos dos fármacos , Fenóis/toxicidade , Sistema Hipófise-Suprarrenal/efeitos dos fármacos , Reprodução/efeitos dos fármacos , Animais , Ciclo Estral/efeitos dos fármacos , Feminino , Masculino , Ovário/efeitos dos fármacos , Gravidez , Ratos
10.
Reprod Toxicol ; 51: 145-56, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25615539

RESUMO

Neonatal exposure to 17alpha-ethynylestradiol (EE) causes delayed effect, a late-occurring irreversible damage to reproductive functions characterized by the early onset of age-matched abnormal estrous cycling. To clarify the involvement of a hypothalamic key cycling regulator KiSS1/GPR54 in the delayed effect, we investigated artificially induced LH surges and KiSS1 mRNA expression in the anteroventral periventricular nucleus (AVPV) of cycling young adult rats neonatally exposed to EE, and compared these parameters to those in about 5 months old middle-aged rats. KiSS1 mRNA expression, the number of KiSS1-positive cells and KiSS1/ERα co-expressing cells in the AVPV decreased in both EE-exposed and middle-aged rats. The peak area and levels of LH surge dose-dependently decreased in EE-exposed rats, and reduction was more evident in middle-aged rats. These results indicate that the prior attenuation of KiSS1 and consequent depression of LH surges plays a key role in the onset of abnormal estrous cycling in the delayed effect.


Assuntos
Etinilestradiol/toxicidade , Hipotálamo Anterior/efeitos dos fármacos , Kisspeptinas/genética , Hormônio Luteinizante/sangue , Efeitos Tardios da Exposição Pré-Natal/induzido quimicamente , Animais , Feminino , Hormônio Foliculoestimulante/sangue , Hipotálamo Anterior/metabolismo , Gravidez , RNA Mensageiro/metabolismo , Ratos , Receptores Acoplados a Proteínas G/genética , Receptores de Kisspeptina-1 , Transdução de Sinais/efeitos dos fármacos
11.
Toxicol Appl Pharmacol ; 246(3): 128-40, 2010 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-20423715

RESUMO

To clarify the involvement of signaling of transforming growth factor (TGF)-ß during the hepatocarcinogenesis, the immunohistochemical distribution of related molecules was analyzed in relation with liver cell lesions expressing glutathione S-transferase placental form (GST-P) during liver tumor promotion by fenbendazole, phenobarbital, piperonyl butoxide, or thioacetamide, using rats. Our study focused on early-stage promotion (6weeks after starting promotion) and late-stage promotion (57weeks after starting promotion). With regard to Smad-dependent signaling, cytoplasmic accumulation of phosphorylated Smad (phospho-Smad)-2/3 - identified as Smad3 by later immunoblot analysis - increased in the subpopulation of GST-P(+) foci, while Smad4, a nuclear transporter of Smad2/3, decreased during early-stage promotion. By late-stage promotion, GST-P(+) lesions lacking phospho-Smad2/3 had increased in accordance with lesion development from foci to carcinomas, while Smad4 largely disappeared in most proliferative lesions. With regard to Smad-independent mitogen-activated protein kinases, GST-P(+) foci that co-expressed phospho-p38 mitogen-activated protein kinase increased during early-stage promotion; however, p38-downstream phospho-activating transcriptional factor (ATF)-2, ATF3, and phospho-c-Myc, were inversely downregulated without relation to promotion. By late-stage promotion, proliferative lesions downregulated phospho-ATF2 and phospho-c-Myc along with lesion development, as with downregulation of phospho-p38 in all lesions. These results suggest that from the early stages, carcinogenic processes were facilitated by disruption of tumor suppressor functions of Smad-dependent signaling, while Smad-independent activation of p38 was an early-stage phenomenon. GST-P(-) foci induced by promotion with agonists of peroxisome proliferator-activated receptor-α did not change Smad expression, suggesting an aberration in the Smad-dependent signaling prerequisites for induction of GST-P(+) proliferative lesions.


Assuntos
Carcinogênese/patologia , Glutationa S-Transferase pi/metabolismo , Neoplasias Hepáticas Experimentais/patologia , Proteínas Smad/metabolismo , Fator 2 Ativador da Transcrição/genética , Fator 2 Ativador da Transcrição/metabolismo , Fator 3 Ativador da Transcrição/genética , Fator 3 Ativador da Transcrição/metabolismo , Animais , Carcinogênese/genética , Carcinogênese/metabolismo , Carcinógenos/toxicidade , Modelos Animais de Doenças , Proteínas da Matriz Extracelular/genética , Proteínas da Matriz Extracelular/metabolismo , Genes myc , Glutationa S-Transferase pi/genética , Neoplasias Hepáticas Experimentais/induzido quimicamente , Neoplasias Hepáticas Experimentais/genética , Neoplasias Hepáticas Experimentais/metabolismo , Masculino , Proteínas Serina-Treonina Quinases/genética , Proteínas Serina-Treonina Quinases/metabolismo , Ratos , Ratos Endogâmicos F344 , Receptor do Fator de Crescimento Transformador beta Tipo I , Receptores de Fatores de Crescimento Transformadores beta/genética , Receptores de Fatores de Crescimento Transformadores beta/metabolismo , Transdução de Sinais , Proteínas Smad/genética , Fator de Crescimento Transformador beta/genética , Fator de Crescimento Transformador beta/metabolismo , Proteínas Quinases p38 Ativadas por Mitógeno/genética , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo
12.
Chem Biol Interact ; 185(3): 189-201, 2010 May 14.
Artigo em Inglês | MEDLINE | ID: mdl-20302851

RESUMO

To investigate liver tumor promotion mechanisms of copper (Cu)- and iron (Fe)-overloading, immunolocalization of metal-related biomolecules and lipid peroxidation end products was examined in preneoplastic liver cell foci that expressed glutathione S-transferase placental form (GST-P) in early-stage tumor promotion over 6 weeks in a rat two-stage hepatocarcinogenesis model. Gene expression and concentrations of thiobarbituric acid-reactive substance (TBARS) in the liver were also analyzed. Cu-overloading alone exerted a weak promoting activity, which was enhanced by Fe-overloading. By Cu-overloading, GST-P(+) foci that co-expressed transferrin receptors or downregulated ceruloplasmin increased, suggesting preneoplastic lesion-specific enhancement of oxidative cellular stress. Cu-overloading also increased transcripts of antioxidant enzymes (Gstm3 and Gst Yc2 subunit), cell proliferation, and numbers of single liver cells expressing GST-P or heme oxygenase-1 (HO-1) in the liver, suggesting that oxidative stress induces single-cell toxicity, with the ensuing regeneration contributing to tumor promotion. Fe-overloading increased liver TBARS and HO-1-expressing Kupffer cells, the latter suggesting protection against inflammatory stimuli causing fluctuating proinflammatory cytokine mRNA levels. By co-overloading of Cu and Fe, Cu-overload-related single liver cell toxicity and regeneration increased, as did cytokine imbalances involving increased cyclooxygenase-2-producing Kupffer cells and accumulation of malondialdehyde within GST-P(+) foci. These results suggest an involvement of oxidative stress responses in Cu-induced tumor promotion and Fe-induced enhancement by increasing cytokine imbalances and GST-P(+) foci-specific lipid peroxidation.


Assuntos
Cobre/metabolismo , Sobrecarga de Ferro/metabolismo , Ferro/metabolismo , Neoplasias Hepáticas Experimentais/metabolismo , Estresse Oxidativo , Animais , Testes de Carcinogenicidade , Carcinógenos/toxicidade , Dietilnitrosamina/toxicidade , Glutationa Transferase/metabolismo , Imuno-Histoquímica , Fígado/enzimologia , Fígado/metabolismo , Fígado/patologia , Neoplasias Hepáticas Experimentais/patologia , Masculino , Ratos , Ratos Endogâmicos F344 , Substâncias Reativas com Ácido Tiobarbitúrico/análise , Substâncias Reativas com Ácido Tiobarbitúrico/metabolismo , Fatores de Tempo
13.
Arch Toxicol ; 84(6): 493-500, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20127075

RESUMO

Wy-14,643 (WY), a peroxisome proliferator-activated receptor-alpha agonist, and piperonyl butoxide (PBO), a pesticide synergist, induce oxidative stress and promote hepatocarcinogenesis in the liver of rodents. These chemicals belong to a class of non-genotoxic carcinogens, but DNA damage secondary to the oxidative stress resulting from reactive oxygen species generation is suspected in rodents given these chemicals. To examine whether WY or PBO have DNA-damaging potential in livers of rats subjected to repeated oral administration for 14 days, the in vivo liver comet assay was performed in partially hepatectomized rats, and the expression of some DNA-repair genes was examined. Then, to examine whether they have genotoxic potential, the in vivo liver initiation assay was performed in rats. In the comet assay, positive results were obtained at 3 h after the last treatment of WY, and some DNA-repair genes such as Apex1, Mlh1, Xrcc5, and Gadd45 were up-regulated in the liver. In the liver initiation assay, negative results were obtained for both WY and PBO. The results of the present study suggest that WY, but not PBO, causes some DNA damage in livers of rats, but such DNA damage was repaired by the increased activity of some DNA repair genes and may not lead to a DNA mutation.


Assuntos
Fígado/efeitos dos fármacos , Mutagênicos/toxicidade , Peroxissomos , Sinergistas de Praguicidas/toxicidade , Butóxido de Piperonila/toxicidade , Pirimidinas/toxicidade , Administração Oral , Animais , Ensaio Cometa , DNA/efeitos dos fármacos , Dano ao DNA , Reparo do DNA/genética , Hepatectomia , Fígado/cirurgia , Masculino , Mutagênicos/classificação , Estresse Oxidativo/efeitos dos fármacos , PPAR alfa/agonistas , Pirimidinas/classificação , Ratos , Ratos Endogâmicos F344
14.
Arch Toxicol ; 84(4): 319-31, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20091025

RESUMO

To elucidate the role of metal-related molecules in hepatocarcinogenesis, we examined immunolocalization of transferrin receptor (Tfrc), ceruloplasmin (Cp) and metallothionein (MT)-1/2 in relation to liver cell foci positive for glutathione-S-transferase placental form (GST-P) in the early stage of tumor promotion by fenbendazole (FB), phenobarbital, piperonyl butoxide or thioacetamide in a rat two-stage hepatocarcinogenesis model. To estimate the involvement of oxidative stress responses to the promotion, immunolocalization of 4-hydroxy-2-nonenal, malondialdehyde and acrolein was similarly examined. Our findings showed that MT-1/2 immunoreactivity was not associated with the cellular distribution of GST-P and proliferating cell nuclear antigen, suggesting no role of MT-1/2 in hepatocarcinogenesis. We also found enhanced expression of Tfrc after treatment with strong tumor-promoting chemicals. With regard to Cp, the population showing down-regulation was increased in the GST-P-positive foci in relation to tumor promotion. Up-regulation of Tfrc and down-regulation of Cp was maintained in GST-P-positive neoplastic lesions induced after long-term promotion with FB, suggesting the expression changes occurring downstream of the signaling pathway involved in the formation of GST-P-positive lesions. Furthermore, enhanced accumulation of lipid peroxidation end products was observed in the GST-P-positive foci by promotion. Post-initiation treatment with peroxisome proliferator-activated receptor alpha agonists did not enhance any such distribution changes in GST-P-negative foci. The results thus suggest that facilitation of lipid peroxidation is involved in the induction of GST-P-positive lesions by tumor promotion from an early stage, and up-regulation of Tfrc and down-regulation of Cp may be a signature of enhanced oxidative cellular stress in these lesions.


Assuntos
Ceruloplasmina/metabolismo , Glutationa S-Transferase pi/metabolismo , Peroxidação de Lipídeos , Neoplasias Hepáticas Experimentais/metabolismo , Fígado/metabolismo , Receptores da Transferrina/metabolismo , Animais , Testes de Carcinogenicidade , Carcinógenos , Cobre/metabolismo , Modelos Animais de Doenças , Regulação para Baixo , Regulação Neoplásica da Expressão Gênica , Ferro/metabolismo , Neoplasias Hepáticas Experimentais/etiologia , Masculino , Metalotioneína/metabolismo , Estresse Oxidativo , PPAR alfa/metabolismo , Ratos , Ratos Endogâmicos F344 , Regulação para Cima
15.
Toxicology ; 268(3): 213-8, 2010 Feb 09.
Artigo em Inglês | MEDLINE | ID: mdl-20045035

RESUMO

To investigate the modifying effect of enzymatically modified isoquercitrin (EMIQ) on hepatocellular tumor promotion induced by beta-naphthoflavone (BNF) treatment, male rats were administered a single intraperitoneal injection of N-diethylnitrosamine (DEN) and were fed a diet containing BNF (0.5%) for 6 weeks with or without EMIQ (0.2%) in the drinking water after DEN initiation. One week after the commencement of the administration of BNF, rats were subjected to a two-thirds partial hepatectomy. The number and area of GST-P positive foci, the number of COX2-positive cells and the area of elastica-van Gieson (EVG)-positive connective tissue fibers promoted by BNF were significantly suppressed by the administration of the antioxidant EMIQ. Real-time RT-PCR analysis revealed that EMIQ treatment decreased mRNA expression levels of Gstm1, Serpine1, Cox2 and Nfkbia and increased mRNA expression levels of Yc2 compared with those in the DEN-BNF group. These results suggest that co-administration of EMIQ suppresses the hepatocellular tumor-promoting activity of BNF in rats through the anti-inflammatory effects of EMIQ and restores the cellular redox balance altered by BNF.


Assuntos
Anticarcinógenos , Antioxidantes/química , Antioxidantes/farmacologia , Lesões Pré-Cancerosas/prevenção & controle , Quercetina/análogos & derivados , beta-Naftoflavona/antagonistas & inibidores , beta-Naftoflavona/toxicidade , Animais , Tecido Conjuntivo/efeitos dos fármacos , Tecido Conjuntivo/metabolismo , Ciclo-Oxigenase 2/metabolismo , Glutationa Peroxidase/metabolismo , Imuno-Histoquímica , Neoplasias Hepáticas Experimentais/induzido quimicamente , Neoplasias Hepáticas Experimentais/patologia , Masculino , Lesões Pré-Cancerosas/patologia , Quercetina/química , Quercetina/farmacologia , RNA Mensageiro/biossíntese , RNA Mensageiro/genética , Ratos , Ratos Endogâmicos F344 , Reação em Cadeia da Polimerase Via Transcriptase Reversa
16.
J Vet Med Sci ; 72(2): 229-34, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19940389

RESUMO

We report a rare case of benign sex cord-stromal tumor consisted largely of luteoma with minor portion of Sertoli cell tumor located at the position of the left ovary excision in an 11-year-old ovariectomized bitch. Granulosa cell component was lacking, and both luteal and Sertoli cell portions were entirely positive for inhibin alpha and neuron-specific enolase, whereas luteoma portion alone was positive for Wilms' tumor-1 (WT1), immunohistochemically. The results suggest that this tumor is a possible complication of incomplete ovarian excision at the time of ovariectomy and consisted of uncommon hybrid of luteal and Sertoli cells to be diagnosed as an unclassified sex cord-stromal tumor if applied in human cases. WT1-expression pattern suggested the signature of the difference in the phenotype of these cell types.


Assuntos
Neoplasias Ovarianas/veterinária , Tumores do Estroma Gonadal e dos Cordões Sexuais/veterinária , Animais , Cães , Feminino , Imuno-Histoquímica/veterinária , Células Lúteas/patologia , Masculino , Neoplasias Ovarianas/patologia , Células de Sertoli/patologia , Tumores do Estroma Gonadal e dos Cordões Sexuais/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA